Table 3.
Interaction Analyses of Genetic Risk Score and Breast Cancer Risk Factors Among 6,408 Chinese Women, the Shanghai Breast Cancer Genetics Study, 1996–1998 and 2002–2005
Characteristic or Risk Factor | Genetic Risk Scorea |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Continuous |
By Tertiles |
|||||||||
ORb | 95% CI | P valuec | <7.3 |
7.3–9.7 |
>9.7 |
P valuec | ||||
ORb | 95% CI | ORb | 95% CI | ORb | 95% CI | |||||
All women | 1.13* | 1.11, 1.14 | 8.01 × 10−29* | 1.00 | Referent | 1.38* | 1.21, 1.56 | 1.89* | 1.68, 2.14 | 4.65 × 10−25* |
Age at menarche, years | ||||||||||
>13 | 1.10* | 1.08, 1.12 | 0.743 | 1.00 | Referent | 1.35* | 1.16, 1.58 | 1.90* | 1.64, 2.20 | 0.893 |
≤13 | 1.11* | 1.07, 1.14 | 1.23* | 1.00, 1.50 | 1.77* | 1.45, 2.14 | 2.30* | 1.92, 2.77 | ||
Age at menopause, yearsd | ||||||||||
≤50 | 1.09* | 1.06, 1.13 | 0.768 | 1.00 | Referent | 1.11 | 0.88, 1.41 | 1.55* | 1.24, 1.93 | 0.343 |
>50 | 1.10* | 1.05, 1.15 | 1.03 | 0.76, 1.39 | 1.34 | 1.00, 1.79 | 1.93* | 1.44, 2.57 | ||
Years of menstruation | ||||||||||
30 | 1.09* | 1.06, 1.12 | 0.194 | 1.00 | Referent | 1.35* | 1.10, 1.65 | 1.77* | 1.45, 2.15 | 0.301 |
>30 | 1.11* | 1.09, 1.14 | 1.16 | 0.95, 1.41 | 1.63* | 1.35, 1.99 | 2.30* | 1.91, 2.78 | ||
Parity/age at first live birth, years | ||||||||||
≤25 | 1.12* | 1.09, 1.15 | 0.570 | 1.00 | Referent | 1.12 | 0.92, 1.37 | 1.79* | 1.48, 2.17 | 0.644 |
>25 or nulliparous | 1.11* | 1.08, 1.13 | 1.12 | 0.93, 1.35 | 1.76* | 1.46, 2.11 | 2.19* | 1.83, 2.62 | ||
Total breastfeeding, months | ||||||||||
>12 total | 1.10* | 1.06, 1.13 | 0.621 | 1.00 | Referent | 1.18 | 0.91, 1.51 | 1.73* | 1.36, 2.21 | 0.456 |
≤12 | 1.11* | 1.08, 1.13 | 1.18 | 0.94, 1.47 | 1.72* | 1.37, 2.15 | 2.31* | 1.85, 2.87 | ||
Family history of breast cancer | ||||||||||
No | 1.10* | 1.08, 1.12 | 0.897 | 1.00 | Referent | 1.33* | 1.16, 1.52 | 1.86* | 1.64, 2.11 | 0.811 |
Yes | 1.10* | 1.01, 1.21 | 2.02* | 1.18, 3.48 | 1.65* | 1.02, 2.68 | 3.29* | 2.13, 5.07 | ||
History of benign breast disease | ||||||||||
No | 1.09* | 1.07, 1.12 | 0.789 | 1.00 | Referent | 1.28* | 1.08, 1.51 | 1.80* | 1.53, 2.10 | 0.824 |
Yes | 1.11* | 1.07, 1.13 | 1.66* | 1.36, 2.02 | 2.22* | 1.84, 2.70 | 3.09* | 2.59, 3.70 | ||
Hormone replacement therapy | ||||||||||
No | 1.10* | 1.08, 1.12 | 0.836 | 1.00 | Referent | 1.38* | 1.22, 1.57 | 1.91* | 1.68, 2.16 | 0.401 |
Yes | 1.10 | 1.00, 1.21 | 1.53 | 0.92, 2.56 | 1.76* | 1.07, 2.89 | 2.24* | 1.47, 3.43 | ||
Body mass indexe | ||||||||||
≤25 | 1.10* | 1.08, 1.13 | 0.735 | 1.00 | Referent | 1.49* | 1.28, 1.73 | 1.86* | 1.61, 2.15 | 0.303 |
>25 | 1.11* | 1.07, 1.14 | 1.36* | 1.11, 1.66 | 1.58* | 1.30, 1.93 | 2.81* | 2.32, 3.40 | ||
Waist/hip ratio | ||||||||||
≤0.81 | 1.11* | 1.08, 1.14 | 0.779 | 1.00 | Referent | 1.49* | 1.23, 1.80 | 2.00* | 1.66, 2.40 | 0.570 |
>0.81 | 1.10* | 1.08, 1.13 | 1.75* | 1.45, 2.11 | 2.33* | 1.93, 2.81 | 3.24* | 2.70, 3.89 | ||
Regular physical activityf | ||||||||||
Yes | 1.11* | 1.08, 1.13 | 0.990 | 1.00 | Referent | 1.00 | 0.77, 1.28 | 1.76* | 1.39, 2.22 | 0.682 |
No | 1.10* | 1.08, 1.12 | 1.17 | 0.95, 1.45 | 1.70* | 1.37, 2.09 | 2.24* | 1.82, 2.74 |
Abbreviations: CI, confidence interval; OR, odds ratio.
* P ≤ 0.05 (significant).
a Genetic risk score based on genotypes for rs4973768, rs10941679, rs889312, rs2046210, rs13281615, rs704010, rs1219648, rs3817198, rs3803662, and rs4784227.
b Derived from logistic regression, adjusted for age and education.
c P value for association or trend for genetic risk score among all women; P values for interaction in stratified analyses.
d Among postmenopausal women.
e Body mass index: weight (kg)/height (m)2.
f Among women from case-control studies.